Synergistic activity of azoles with amiodarone against clinically resistant Candida albicans tested by chequerboard and time-kill methods

Journal of Medical Microbiology

Volumn 57, Issue 4, 2008, Pages 457-462

  Guo, Qiongjie ^a   Sun, Shujuan ^b   Yu, Jinlong ^a   Li, Yan ^b   Cao, Lili ^b  

^a SHANDONG UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SHANDONG FIRST MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; FLUCONAZOLE; ITRACONAZOLE; VORICONAZOLE;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; CONTROLLED STUDY; DRUG POTENTIATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

AMIODARONE; ANTIFUNGAL AGENTS; AZOLES; CANDIDA ALBICANS; COLONY COUNT, MICROBIAL; DRUG RESISTANCE, FUNGAL; DRUG SYNERGISM; HUMANS; MICROBIAL SENSITIVITY TESTS;

EID: 42149168443     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.47651-0     Document Type: Article

References (32)

1. Afeltra, J., Vitale, R. G., Mouton, J. W. & Verweij, P. E. (2004). Potent synergistic in vitro interaction between nonantimicrobial membrane-active compounds and itraconazole against clinical isolates of Aspergillus fumigatus resistant to itraconazole. Antimicrob Agents Chemother 48, 1335-1343.
2. Andes, D., Forrest, A., Lepak, A., Nett, J., Marchillo, K. & Lincoln, L (2006). Impact of antimicrobial dosing regimen on evolution of drug resistance in vivo: fluconazole and Candida albicans. Antimicrob Agents Chemother 50, 2374-2383.
3. Barchiesi, F., Di Francesco, L. F., Compagnucci, P., Arzeni, D., Giacometti, A. & Scalise, G. (1998). In-vitro interaction of terbinafine with amphotericin B, fluconazole and itraconazole against clinical isolates of Candida albicans. J Antimicrob Chemother 41, 59-65.
4. Baumgartner, C., Freydiere, A. M. & Gille, Y. (1996). Direct identification and recognition of yeast species from clinical material by using albicans ID and CHROMagar Candida plates. J Clin Microbiol 34, 454-456.
5. CLSI (2002). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. Approved standard M27-A2. Wayne, PA: Clinical Laboratory Standards Institute.
6. Courchesne, W. E. (2002). Characterization of a novel, broad-based fungicidal activity for the antiarrhythmic drug amiodarone. J Pharmacol Exp Ther 300, 195-199.
7. Cruz, M. C., Goldstein, A. L., Blankenship, J. R., Del Poeta, M., Davis, D., Cardenas, M. E., Perfect, J. R., McCusker, J. H. & Heitman, J. (2002). Calcineurin is essential for survival during membrane stress in Candida albicans. EMBO J 21, 546-559.
8. Espinel-Ingroff, A., Barchiesi, F., Cuenca-Estrella, M., Pfaller, M. A., Rinaldi, M., Rodriguez-Tudela, J. L. & Verweij, P. E. (2005a). International and multicenter comparison of EUCAST and CLSI M27-A2 broth microdilution methods for testing susceptibilities of Candida spp. to fluconazole, itraconazole, posaconazole, and voriconazole. J Clin Microbiol 43, 3884-3889.
9. Espinel-Ingroff, A., Barchiesi, F., Cuenca-Estrella, M., Fothergill, A., Pfaller, M. A., Rinaldi, M., Rodriguez-Tudela, J. L. & Verweij, P. E. (2005b). Comparison of visual 24-hour and spectrophotometric 48-hour MICs to CLSI reference microdilution MICs of fluconazole, itraconazole, posaconazole, and voriconazole for Candida spp.: a collaborative study. J Clin Microbiol 43, 4535-4540.
10. Filler, S. G. & Sheppard, D. C. (2006). Fungal invasion of normally non-phagocytic host cells. PLoS Pathog 2, e129.
11. Fricker-Hidalgo, H., Vandapel, O., Duchesne, M. A., Mazoyer, M. A., Monget, D., Lardy, B., Lebeau, B., Freney, J., Ambroise-Thomas, P. & Grillot, R. (1996). Comparison of the new API Candida system to the ID 32C system for identification of clinically important yeast species. J Clin Microbiol 34, 1846-1848.
12. Ghannoum, M. A., Fu, Y., Ibrahim, A. S., Mortara, L. A., Shafiq, M. C., Edwards, J. E., Jr & Criddle, R. S. (1995). In vitro determination of optimal antifungal combinations against Cryptococcus neoformans and Candida albicans. Antimicrob Agents Chemother 39, 2459-2465.
13. Girmenia, C., Venditti, M. & Martino, P. (2003). Fluconazole in combination with flucytosine in the treatment of fluconazole-resistant Candida infections. Diagn Microbiol Infect Dis 46, 227-231.
14. Gupta, S. S., Ton, V. K., Beaudry, V., Rulli, S., Cunningham, K. & Rao, R. (2003). Antifungal activity of amiodarone is mediated by disruption of calcium homeostasis. J Biol Chem 278, 28831-28839.
15. Klepser, M. E., Ernst, E. J., Lewis, R. E., Ernst, M. E & Pfaller, M. A. (1998). Influence of test conditions on antifungal time-kill curve results: proposal for standardized methods. Antimicrob Agents Chemother 42, 1207-1212.
16. Kuhn, D. M., Chandra, J., Mukherjee, P. K. & Ghannoum, M. A. (2002). Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces. Infect Immun 70, 878-888.
17. Kuhn, D. M., Balkis, M., Chandra, J., Mukherjee, P. K. & Ghannoum, M. A. (2003). Uses and limitations of the XTT assay in studies of Candida growth and metabolism. J Clin Microbiol 41, 506-508.
18. Lewis, R. E. & Kontoyiannis, D. P. (2005). Micafungin in combination with voriconazole in Aspergillus species: a pharmacodynamic approach for detection of combined antifungal activity in vitro. J Antimicrob Chemother 56, 887-892.
19. Meletiadis, J., Mouton, J. W., Meis, J. F. & Verweij, P. E. (2003). In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedosporium prolificans isolates. Antimicrob Agents Chemother 47, 106-117.
20. Morschhäuser, J. (2002). The genetic basis of fluconazole resistance development in Candida albicans. Biochim Biophys Acta 1587, 240-248.
21. Mukherjee, P. K., Sheehan, D. J., Hitchcock, C. A. & Ghannoum, M. A. (2005). Combination treatment of invasive fungal infections. Clin Microbiol Rev 18, 163-194.
22. Nicolay, J. P., Bentzen, P. J., Ghashghaeinia, M., Wieder, T. & Lang, F. (2007). Stimulation of erythrocyte cell membrane scrambling by amiodarone. Cell Physiol Biochem 20, 1043-1050.
23. Odds, F. C. (2003). Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother 52, 1.
24. Pfaller, M. A., Houston, A. & Coffmann, S. (1996). Application of CHROMagar Candida for rapid screening of clinical specimens for Candida albicans, Candida tropicalis, Candida krusei and Candida (Torulopsis) glabrata. J Clin Microbiol 34, 58-61.
25. Pfaller, M. A., Boyken, L., Hollis, R. J., Messer, S. A., Tendolkar, S. & Diekema, D. J. (2005). In vitro susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species to itraconazole: global survey of 9,359 isolates tested by Clinical and Laboratory Standards Institute broth microdilution methods. J Clin Microbiol 43, 3807-3810.
26. Quan, H., Cao, Y. Y., Xu, Z., Zhao, J. X., Gao, P. H., Qin, X. F. & Jiang, Y. Y. (2006). Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole. Antimicrob Agents Chemother 50, 1096-1099.
27. Ramage, G., Vande Walle, K., Wickes, B. L. & López-Ribot, J. L. (2001). Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob Agents Chemother 45, 2475-2479.
28. Ribeiro, M. A. & Paula, C. R. (2007). Up-regulation of ERG11 gene among fluconazole-resistant Candida albicans generated in vitro: is there any clinical implication? Diagn Microbiol Infect Dis 57, 71-75.
29. Tam, V. H., Schilling, A. N., Lewis, R. E., Melnick, D. A. & Boucher, A. N. (2004). Novel approach to characterization of combined pharmacodynamic effects of antimicrobial agents. Antimicrob Agents Chemother 48, 4315-4321.
30. Te Dorsthorst D. T., Verweij, P. E., Meis, J. F., Punt, N. C. & Mouton, J. W. (2002). Comparison of fractional inhibitory concentration index with response surface modeling for characterization of in vitro interaction of antifungals against itraconazole-susceptible and -resistant Aspergillus fumigatus isolates. Antimicrob Agents Chemother 46, 702-707.
31. Te Dorsthorst D. T., Verweij, P. E., Meis, J. F., Punt, N. C. & Mouton, J. W. (2004). In vitro interactions between amphotericin B, itraconazole, and flucytosine against 21 clinical Aspergillus isolates determined by two drug interaction models. Antimicrob Agents Chemother 48, 2007-2013.
32. Vassallo, P. & Trohman, R. G. (2007). Prescribing amiodarone: an evidence-based review of clinical indications. JAMA 298, 1312-1322.